A simultaneous fluorometric determination method of S-sulfocysteine and S-sulfoglutathione was established by HPLC using 7-fluoro-4-nitrobenzo-2-oxa-l,3-diazole (NBD-F) as a prelabeling reagent. Chromatographic conditions were as follows: Column, TSK gel NH2-60 (150 mmx4 mm id.); eluent, 0.1 M citrate buffer (pH 3.0) containing 10% methanol; flow rate, 1.0 ml/min; sample size, 100 µl; detection, Ex 475, Em 545 nm. Calibration curves for S-Sulfocysteine and S-sulfoglutathione were linear over the range of 0.1 to 10 nmol. S-Sulfoglutathione was identified as an endogenous compound in rabbit red blood cells by the use of the present method. This method was also applied to the determination of S-sulfocysteine and S-sulfoglutathione in rabbit plasma and red blood cells after injection of sodium bisulfite.
Sulfite is widely used as an antioxidant for the stabilization of injections, and is mostly converted to sulfate in mammalian bodies by sulfite oxidase.1 It is also known that S-sulfo group (R-SS03H) are produced by the reaction of sulfite with disulfide bonds in plasma when sulfite is injected into experimental animals. 2 A large number of reports have been published about protein-bound S-sulfo residues in plasma of several animals.2 '3 Furthermore, Ssulfocysteine and S-sulfoglutathione were produced by the reaction of cystine or oxidized glutathione with sulfite under physiological conditions.4 S-Sulfocysteine was isolated in normal human urines, and remarkably high concentrations of S-sulfocysteine were found in the urine of patients suffering from sulfite oxidase deficiency. 6 Walley reported the isolation of Ssulfoglutathione from mammalian lens.' These compounds were determined by thin-layer chromatography with ninhydrin detection.
Recently, liquid chromatographic methods for the determination of Ssulfocysteine and S-sulfoglutathione have been reported.8'9 However, these methods were inadequate for routine analysis because their operations were timeconsuming.
In this report, we studied an HPLC method for simple and simultaneous determination of S-sulfocysteine and S-sulfoglutathione in blood using 7-fluoro-4-nitrobenzo-2-oxa-l,3-diazole (NBD-F) as a prelabeling reagent.
Then this method was applied to the determination of S-sulfocysteine and S-sulfoglutathione in rabbit blood after injection of sulfite.
Experimental

Reagents
Cystine, oxidized glutatione and NBD-F were obtained from Wako Pure Chemicals (Tokyo, Japan). Sodium bisulfite was purchased from Kanto Chemical Co., Inc (Tokyo, Japan).
Sodium S-sulfocysteine monohydrate and barium salt of S-sulfoglutathione were synthesized by the methods of Sorbo10 and Pasternak" respectively. All other chemicals were of analytical grade.
The standard solutions of Ssulfonates were prepared by dissolving in deionized and distilled water. They were stored at 4°C in the dark and were used by diluting the solution before use.
HPLC system
The chromatographic equipment included a reciprocating pump (PSU-2.5, Seishin Pharmaceutical Co., Tokyo, Japan), a variable input recorder (SS-250F, Sekonic Co., Tokyo, Japan) and a Shimadzu RF-530 fluorescence detector (Shimadzu Seisakusho Co., Kyoto, Japan). Excitation and emission wavelengths of the detector were set at 475 and 545 nm, respectively. An analytical column (4 mm i.d.X 150 mm) packed with TSK gel NH2-60 (Toyo Soda Co., Tokyo, Japan) was used. Citrate buffer (0.1 M, pH 3.0) containing 10% methanol (v/ v) was used as a mobile phase at a flow rate of 1.0 ml/ min.
Preparation of biological materials
Fresh heparinized blood, obtained from a rabbit in the usual manner was centrifuged at 1000Xg for 20 min, and the plasma was transferred to a plastic tube.
Red blood cells were washed three times with 35 mM phosphate buffer containing 0.15 M NaCI and centrifuged at 1000Xg for 20 min.
Procedure for the determination of S sulfocysteine and S sulfoglutathione Plasma: To 100 µl of plasma, 500 µl of ethanol was added and the mixture was centrifuged at 7000Xg for 5 min. The supernatant was submitted to the derivatization method reported by Imai et a1.12 as follows: To 20 µl sample solution, 20 µl of 0.1 M borate buffer (pH 8.0) and 40 µl of 10 mM NBD-F in ethanol were added, and the mixture was heated at 60° C for 1 min. The reaction was stopped with the addition of 120 µl of 0.1 M HCl in 50% ethanol and the reaction mixture was submitted to HPLC.
Red blood cells: A 250 µl portion of red blood cells was hemolyzed with an equal volume of cold distilled water. To the hemolyzate, 500 .tl of ethanol and 250 µl of chloroform were added with constant stirring according to the Tsuchihashi's procedure. 13 The denaturated hemoglobin was centrifuged off at 7000X g for 5 min. The supernatant was mixed with 3 ml of distilled water, then the mixture was passed through a column packed with 2 ml of Dowex 50WX8 (100-200 mesh, H+ form). The column was washed with 2 ml of distilled water and the combined eluates and washings were taken to dryness on an evaporator. The residue was suspended in 250 µl of distilled water and derivatized with NBD-F.
Procedure for the determination of S sulfo group Determination of S-sulfo group was carried out by a method developed by us.14 A 250 µl portion of sample was mixed with 250 µl of a solution containing 20 mM dithiothreitol and 5 mM EDTA in 5U mM Tris-HC1 buffer (pH 9.2); the mixture was warmed at 37° C for 15 min. The sulfite liberated was converted to sulfur dioxide by acidification and absorbed to monoethanolamine solution by aeration.
Then an adduct was prepared by the reaction of sulfite with p-aminoazobenzene and formaldehyde and determined by HPLC with colorimetric detection.
In vivo experiment
An in vivo experiment was performed with 3.0 kg male Japanese white rabbit maintained on a diet of high fiber rabbit pellets. Injection solutions were adjusted to pH 7.4 with sodium hydroxide. A dose of 0.5 mmol/kg body weight contained in volume of 2 ml was injected intravenously.
Results and Discussion
Separation of NBD S sulfocysteine and NBD 5-sulfoglutathione by HPLC Plasma and red blood cells contain a large amount of amino acids which were easily derivatized with NBD-F and they interfere with the determination of NBD S-sulfocysteine and NBD S-sulfoglutathione. Therefore, their separation from common amino acids was investigated using amino bonded silica column and 0.1 M citrate buffer containing 10% methanol. NBD S-sulfocysteine and NBD S-sulfoglutathione were separated by changing the pH of citrate buffer, and tailing of the peaks was suppressed by the addition of methanol to the eluent. Under these chromatographic conditions, NBD S-sulfocysteine and NBD S-sulfoglutathione were eluted at the retention times of 19.5 and 34.5 min, and calibration curves were linear over the range of 0.1 to 10 nmol at a sample size of 100 sl (r=0.999).
A typical chromatogram of NBD Ssulfocysteine and NBD S-sulfoglutathione is shown in Fig. 1 .
Retention times of NBD amino acids are shown in Table 1 . None of them interfered with NBD Ssulfocysteine and NBD S-sulfoglutathione determina- Fig. 1 Chromatogram of S-sulfocysteine and S-sulfoglutathione. I, S-sulfocysteine; II, S-sulfoglutathione, 50 µM.
HPLC conditions are given in the experimental section. Table 2 .
Neither S-sulfocysteine nor S-sulfoglutathione was detected in normal rabbit plasma.
Identification of S sulfoglutathione in rabbit red blood cells The present method was also applied to the determination of S-sulfonates in red blood cells, which were treated with ethanol and chloroform according to the Tsuchihashi's method.13 When the supernatant was submitted to the derivatization and analyzed by HPLC, the recovery of S-sulfonates from red blood cells was fairly low, and the unknown peaks were eluted. Therefore a cation exchange resin was necessary to remove interfering compounds. A chromatogram of rabbit red blood cells after the pretreatment described in the experimental section is shown in Fig. 2 ; here a sharp S-sulfoglutathione peak was observed. Identification of the peak corresponding to NBD Ssulfoglutathione was performed by measuring the Ssulfo group. Concentrations of S-sulfoglutathione in rabbit blood red cells agreed with the total S-sulfo group content measured by the above method. Moreover, the peak of NBD S-sulfoglutathione obtained from the sample disappeared by the reduction of Ssulfo group. From these results, we have identified Ssulfoglutathione in rabbit red blood cells. Analytical values of S-sulfoglutathione and its recoveries are shown in Table 3 .
In this experiment, no Ssulfocysteine was detected (limit of detection=0 .5 nmol/ ml red blood cells). The average concentration of S-sulfoglutathione in rabbit red blood cells was 6.8 µM (n=5, RSD 1.6%). Its physiological role is not clear and must be studied further.
Determination of S sulfocysteine and S sulfoglutathione after administration of sodium bisulfate to rabbit A large number of reports have been published about the formation of protein S-sulfonates in plasma after administration of sulfite.2,3 But low-molecular Table  2 Recovery tests of S-sulfocysteine tathione from rabbit plasma and S-sulfoglu- Table  3 Analytical results and tathione in rabbit red blood cells recoveries of S-sulfoglu-weight S-sulfonates in blood could not be determined. Therefore, we applied our method to the determination of S-sulfocysteine and S-sulfoglutathione in blood after injection of sodium bisulfate. Figure 3 shows the timecourse of S-sulfonate levels in plasma and red blood cells. S-Sulfocysteine was formed immediately after injection. The ratio of S-sulfocysteine to total Ssulfonates were about 25% at 30 min after injection. When the concentration of S-sulfonates reached a maximum, a small amount of S-sulfoglutathione was found in the plasma. Furthermore, the concentration of S-sulfoglutathione in red blood cells did not change after the injection. These data can be explained by the low content of the oxidized glutathione in blood. Sulfite is a very reactive ionic species which interacts with molecules of biological importance in potentially toxic reactions. But some animal studies have shown that exposure of sulfur dioxide and dietary bisulfite is relatively harmless.15 This is due to the presence of sulfite oxidase and binding of free sulfite with disulfide bonds in plasma. It is noteworthy that the sulfite contained in injections as an antioxidant is recently of interest because it causes allergic-type reactions in susceptible individuals. 16 The present method will make important contributions to studies on the metabolism of sulfite.
